Location: Stockholm, Sweden
CIK: 0001381843 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 4, 2025
Total Value: $26.97M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | 37,244 | $3.017M | 11.2% | $707.31 | +4.9% | COM | 532457108 |
| ABBV | AbbVie Inc | 92,105 | $2.264M | 8.4% | $167.10 | +20.9% | COM | 00287Y109 |
| NBIX | Neurocrine Biosciences Inc | 102,625 | $1.529M | 5.7% | $130.83 | +3.6% | COM | 64125C109 |
| MRK | Merck & Co. Inc | 160,913 | $1.434M | 5.3% | $99.86 | -18.9% | COM | 58933Y105 |
| TMO | Thermo Fisher Scientific Corp | 27,147 | $1.398M | 5.2% | $514.63 | -9.7% | COM | 883556102 |
| ONC | BeiGene Ltd | 30,333 | $1.097M | 4.1% | $195.10 | — | SPONSORED ADS | 07725L102 |
| BBIO | Bridgebio Pharma Inc | 174,722 | $963K | 3.6% | $31.34 | +55.6% | COM | 10806X102 |
| COR | Cencora Inc | 28,608 | $949K | 3.5% | $208.00 | +41.1% | COM | 03073E105 |
| ISRG | Intuitive Surgical Inc | 19,707 | $936K | 3.5% | $543.84 | -11.8% | COM NEW | 46120E602 |
| GILD | Gilead Sciences Inc | 78,169 | $921K | 3.4% | $101.28 | +10.9% | COM | 375558103 |
| BSX | Boston Scientific Corp | 86,680 | $898K | 3.3% | $68.73 | +50.7% | COM | 101137107 |
| SYK | Stryker Corporation | 22,769 | $894K | 3.3% | $317.70 | +21.0% | COM | 863667101 |
| ALKS | Alkermes PLC | 252,875 | $805K | 3.0% | $26.70 | +5.6% | SHS | G01767105 |
| KRYS | Krystal Biotech, Inc | 42,191 | $791K | 2.9% | $151.49 | -1.2% | COM | 501147102 |
| VRTX | Vertex Pharmaceuticals Inc | 17,766 | $739K | 2.7% | $420.60 | -0.6% | COM | 92532F100 |
| MIRM | Mirum Pharmaceuticals Inc | 93,605 | $729K | 2.7% | $36.30 | +75.1% | COM | 604749101 |
| NAMS | NewAmsterdam Pharma Co NV | 193,625 | $585K | 2.2% | $19.65 | +22.0% | ORDINARY SHARES | N62509109 |
| IRTC | iRhythm Technologies Inc | 29,991 | $548K | 2.0% | $117.90 | +34.8% | COM | 450056106 |
| EW | Edwards Lifesciences Corp | 65,659 | $542K | 2.0% | $74.44 | +5.0% | COM | 28176E108 |
| CAH | Cardinal Health Inc | 30,297 | $505K | 1.9% | $78.17 | +96.5% | COM | 14149Y108 |
| UFPT | UFP Technologies Inc | 22,986 | $487K | 1.8% | $277.76 | -20.8% | COM | 902673102 |
| — | Merus N.V. | 47,999 | $480K | 1.8% | $45.53 | — | COM | N5749R100 |
| SLNO | Soleno Therapeutics Inc | 60,156 | $432K | 1.6% | $58.36 | +27.0% | COM | 834203309 |
| RVMD | REVOLUTION Medicines Inc | 85,355 | $423K | 1.6% | $46.20 | -15.3% | COM | 76155X100 |
| AMGN | Amgen Inc | 13,806 | $414K | 1.5% | $267.21 | +7.3% | COM | 031162100 |
| DXCM | Dexcom Inc | 50,872 | $363K | 1.3% | $97.28 | -18.7% | COM NEW | 252131107 |
| BCAX | BICARA THERAPEUTICS INC | 203,755 | $342K | 1.3% | $12.52 | -10.6% | COM | 055477103 |
| IRON | Disc medicine inc | 45,690 | $321K | 1.2% | $52.73 | +12.8% | COM | 254604101 |
| UNH | Universal Health Services Inc | 13,727 | $298K | 1.1% | $502.95 | -40.6% | COM | 91324P102 |
| HRMY | Harmony Bioscience Holdings | 92,074 | $269K | 1.0% | $33.66 | +2.3% | COM | 413197104 |
| RNAM | Avidity Biosciences Inc | 51,978 | $240K | 0.9% | $40.43 | 0.0% | COM | 05370A108 |
| CRBP | Corbus Pharmaceuticals Holding | 175,582 | $236K | 0.9% | $20.42 | -53.4% | COM | 21833P301 |
| ACLX | Arcellx Inc | 25,732 | $224K | 0.8% | $60.03 | +19.9% | COMMON STOCK | 03940C100 |
| SMMT | Summit Therapeutics Inc | 92,737 | $203K | 0.8% | $14.99 | +61.8% | COM | 86627T108 |
| AUTL | Autolus Therapeutics PLC | 1,169,634 | $202K | 0.8% | $2.89 | — | SPON ADS | 05280R100 |
| CELC | Celcuity Inc | 37,157 | $195K | 0.7% | $40.03 | 0.0% | COM | 15102K100 |
| MREO | Mereo Biopharma Group PLC | 764,901 | $167K | 0.6% | $3.28 | — | SPON ADS | 589492107 |
| JANX | Janux Therapeutics Inc | 49,820 | $129K | 0.5% | $49.08 | -50.4% | COM | 47103J105 |